Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.31 USD | -0.60% | -1.42% | +107.75% |
Mar. 15 | XBiotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 04 | XBiotech Inc. to Begin Constructing New R&D Facility on Its 48-Acre Campus | CI |
Financials (USD)
Sales 2022 | 4.01 | Sales 2023 | - | Capitalization | 122M |
---|---|---|---|---|---|
Net income 2022 | -32M | Net income 2023 | -24M | EV / Sales 2022 | -27,590,059 x |
Net cash position 2022 | 217M | Net cash position 2023 | 200M | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.25
x | P/E ratio 2023 |
-4.94
x | Employees | 82 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 64.86% |
1 day | -0.60% | ||
1 week | -1.42% | ||
Current month | +8.34% | ||
1 month | +1.22% | ||
3 months | +28.84% | ||
6 months | +132.12% | ||
Current year | +107.75% |
Managers | Title | Age | Since |
---|---|---|---|
John Simard
CEO | Chief Executive Officer | 62 | 05-03-21 |
Angela Hu
DFI | Director of Finance/CFO | 40 | 14-12-31 |
Mark Ziats
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald MacAdam
BRD | Director/Board Member | 76 | 18-03-19 |
William McKenzie
BRD | Director/Board Member | 76 | 09-01-31 |
John Simard
CEO | Chief Executive Officer | 62 | 05-03-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 8.31 | -0.60% | 92,688 |
24-05-23 | 8.36 | -2.68% | 52,682 |
24-05-22 | 8.59 | -1.72% | 55,781 |
24-05-21 | 8.74 | +2.34% | 51,793 |
24-05-20 | 8.54 | +1.30% | 29,304 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+107.75% | 253M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- XBIT Stock